Ehab Abdelkader

Ehab Abdelkader

Auto-generated profile, based on publicly available information

Ehab Abdelkader

Department of Ophthalmology, Royal Alexandra Hospital, Paisley, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
AAAbdulaziz A. Alshamrani
Abdulaziz A. Alshamrani
OROsama Raddadi
Osama Raddadi
PSPatrik Schatz
Patrik Schatz
SLSteffen Lenzner
Steffen Lenzner
CNChristine Neuhaus
Christine Neuhaus
EAEhab Abdelkader
Ehab Abdelkader
To report a severe phenotype of retinitis pigmentosa associated with novel mutations in CNGB1. Six siblings, age range 50–75 years old, were examined using optical coherence tomography and fundus autofluorescene, electroretinogram testing, Goldman visual field testing, and genetic testing using next generation sequencing. In four affected siblings, two novel compound heterozygous variants in CNGB1 were detected: in exon 26 the missense variant c.2603G > A (p.(Gly868Asp)), and in exon 21, the in-frame 12-bp duplication c.2093_2104dupGCGACCTCATCT (p.(Cys698_lle701dup)). One sibling was unaffected and carried neither of the variants, while another sibling had mild macular degeneration changes and carried the latter variant in heterozygous status. The affected siblings presented with a phenotype showing markedly constricted visual field, flat scotopic and photopic electroretinogram responses and generalized retinal atrophy. This is the first report of a 12bp in-frame duplication and a missense variant (in compound heterozygous status) in CNGB1, being associated with a severe form of retinitis pigmentosa featuring extensive peripheral and central retinal degeneration. This study expands the molecular genetic basis of CNGB1-related disease.

1 January 2019 in Saudi Journal of Ophthalmology
Verified
Journal Article
Open access
KAKhalid Allam
Khalid Allam
NANaif AlMutairi
Naif AlMutairi
AEAmin F. Ellakwa
Amin F. Ellakwa
EAEhab Abdelkader
Ehab Abdelkader
Purpose: To report anatomical and visual outcomes of Nd:YAG laser posterior hyaloidotomy (NYPH) in Saudi patients affected by Premacular subhyaloid haemorrhage (PMSHH). Methods: 8 eyes from 8 patients (7 males and one female) were treated with NYPH when no spontaneous resolution of PMSHH was noticed. The cause of PMSHH was proliferative diabetic retinopathy (PDR) in 3 cases, Central retinal vein occlusion (CRVO) in 2 cases, Valsalva retinopathy in 2 cases, and laser pointer injury in one case. The YAG laser was delivered using a Q switched mode and 3 mirrors contact lens. One attempt of laser delivery was enough in 6 cases and 2 cases needed 2 attempts. The laser power needed ranged between 2 and 4 mJ. Results: Anatomical success was achieved in all cases. The mean LogMAR VA improved from 1.5 before treatment to 0.3 post-treatment. The difference is statistically significant (p = 0.012). No complications related to Nd:YAG laser therapy was reported in any of the study cases until the last follow up. Conclusion: To our knowledge, this is the first study to report the outcomes of NYPH for non-resolving PMSHH in Saudi cases. In this small cases series, the procedure seems to be safe, effective, simple, cheap, and non-invasive treatment modality for this disorder that is conducted in the outpatient setting. We think it should be considered as a first option for cases of SHH covering the fovea due to various aetiologies.

20 January 2020 in Documenta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
EAEhab Abdelkader
Ehab Abdelkader
ZYZ. H. Yasir
Z. H. Yasir
AKAbdullah M. Khan
Abdullah M. Khan
OROsama Raddadi
Osama Raddadi
RKRajiv Khandekar
Rajiv Khandekar
PSPatrik Schatz
Patrik Schatz

1 January 2026 in Delta Journal of Ophthalmology
Verified
Journal Article
Open access
IMIslam A. Mohalhal
Islam A. Mohalhal
AAAbdulaziz A. Alshamrani
Abdulaziz A. Alshamrani
AAAbdukarim Alkharashi
Abdukarim Alkharashi
PSPatrik Schatz
Patrik Schatz
EAEhab Abdelkader
Ehab Abdelkader
Purpose: This study aimed to evaluate the outcome of argon laser therapy for nonresolving central serous chorioretinopathy (CSCR) in a Saudi patient population. Patients and methods: This is a prospective case series study of 20 eyes (20 patients) having nonresolving CSCR. In all of them, no signs of spontaneous improvement were noticed in 3 months. The assessment of the patients, including history taking, visual acuity, full ocular examination using slit lamp biomicroscopy, and fundus fluorescein angiography were done at baseline. Optical coherence tomography was done before treatment and at all follow-up (FU) visits. Fundus autofluorescence was done in 16 cases. The FU was done for 6–30 months (mean=9.7±6.4 months). Results: The age of the patients ranged from 24 to 73 years (mean=43.0±10.9 years). One laser session was enough in 18 (90%) eyes, while two sessions were needed in two (10%) eyes. All study eyes experienced subjective improvement in vision following treatment. The mean LogMAR visual acuity improved from 0.51±0.155 before the laser treatment to 0.23±0.23 at the last FU, with a statistically significant difference ( P =0.000). The mean height of the subretinal fluid at the foveal centre decreased significantly from 196.79±116.7 µm before treatment to 11.16±14.7 µm at the last FU ( P =0.000). The integrity of the inner segment ellipsoid zone and normality of the foveal AF were associated with a better visual outcome. No treatment-related complications were encountered in any case. Conclusion: Although argon laser therapy is an old treatment modality for CSCR, it remains an effective one. It is easy, cheap, readily available, and safe when properly done. Foveal AF appearance and post-treatment inner segment ellipsoid zone integrity are important predictors of visual improvement in CSCR following the argon laser treatment.